ACTIVATION of alveolar macrophages (AM) for tumour necrosis factor production is suppressed initially during the inflammatory response to flbrogerflc dusts. We investigated the mechanisms involved in TNF suppression, notably the role of other AM-derived mediators including prostaglandin Ez (PGE2), transforming growth factor-l (TGF-I), and interleukin 6 (IL-6). The action of PGE2 and TGF-I, on AM was different. At physiologically relevant doses (25-00 pg/ml), PGEz did not cause significant inhibition of Hpopolysaccharide CLps)-induced TNF release by AM in vitro but stimulated IL-6 (up to six fold), an inhibitor of AM-derived TNT. In contrast, TGF-I (0.5-0 ng/ml) inhibited both LPS-induced TNT and IL-6 release by 0% but had no effect on PGEz production by AM. To determine the respective contribution of these different inhibitors in TNF suppression, AM from rats exposed to flbrogenic asbestos for weeks were treated with neutralizing antibody against TGF-I or indomethacin, an inhibitor of PGE2 synthesis. Treatment of rat AM with anti-TGF-but not indomethacin, abrogated the observed TNT suppression. These results suggest that an autocrine, TGF-rdependent mechanism is involved in the down-regulation of TNF production by rat AM from animals with lung fibrosis.
Introduction
Alveolar macrophages (AM) are an important source of numerous cytokines and are a primary cell type in chronic inflammatory reactions induced by fibrogenic dusts. 2 It is likely that the contribution of AM-derived cytokines plays an important role in the maintenance and progression of pulmonary inflammation. Among these, tumour necrosis factor-or (TNF) has attracted much attention owing to a wide range of activities including fibroblast rowth-promoting and growth-inhibiting activities. Together with other cytokines, TNF is frequently found at sites of inflammatory reactions and higher levels of TNF messenger RNA were identified in lung tissue of mice treated with silica 5 and bleomycin. 6 With regard to basal and LPS-stimulated TNF production by AM, variable responses including stimulation as well as inhibition or no change have been reported in experimental silicosis. 7-I0 Less information is available concerning the contribution of AM-derived TNF in asbestos-induced fibrosis. In a previous study, we reported bidirectional changes in LPS-stimulated TNF production by rat AM exposed to fibrogenic asbestos. 9 These changes were characterized initially by a 50% suppression of TNF and were associated with the development of lung fibrosis but were absent in resolving lung granuloma. TNF inhibition was observed at a time when the bronchoalveolar cell population was composed exclusively of macrophages, raising the possibility of a macrophagerelated inhibitory mechanism(s). Therefore, the present work was undertaken to study the role of macrophage-derived mediators, notably PGE2 and TGF-, in the observed TNF suppression.
We report here that down-regulation of AMderived TNF production was completely abrogated by TGF-I3 neutralization whereas indomethacin treatment had no effect. 25 Ig/ml (Fig. 1A) . This is much higher than the levels of PGE2 produced by LPS activated AM (805 pg/ml) ( (25- 300 pg/ml) had a direct stimulatory effect on spontaneous IL-6 release (7 U/ml), an inhibitor of TNF production by rat AM. Up to six-fold stimulation (46 U/ml) was obtained with 300pg/ml PGE2 (Fig. 1B) . In addition, LPS-stimulated IL-6 release (75U/ml) was further increased two-to five-fold by PGE2
within the same concentration range.
On the other hand, TGF-[3 at concentrations ranging between 0.5 and 50ng/ml caused significan inhibition of LPS-induced TNF ( Fig. 2A) and (Fig. 2B) 
